Comser

COMSER is a lyophilization CDMO providing solutions to the biopharmaceutical and biotechnology industries, offering contract services spanning product formulation, lyophilization process development and optimization, GMP equipment qualification and manufacturing process validation, audits of critical providers and high-value training. The company is also building a GMP plant to manufacture small-scale batches for Phase I-II clinical trials, expected to be fully operational by the end of 2026.